New authorisation extends treatment to children with ISS, SGA and Noonan syndrome More: FDA approves once‑weekly Sogroya for wider paediatric use Source: News
read moreAs the effects of the United States and Israel’s weekend attack on Iran begin to ripple through the Middle East, multiple drugmakers operating in the region are taking stock of their local workforces’ safety and committing early to continued medicines
read moreThe newest additions to the CDC’s vaccine advisory committee are Florida internal medicine and pediatrics specialist Sean G. Downing, M.D., and pediatrician Angelina Farella, M.D. More: Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting Source:
read moreWith some 12 years as CEO under his belt, Bavarian Nordic’s Paul Chaplin is telegraphing his exit from the Denmark-based vaccine maker. The planned move comes shortly after another high-profile exit at the company, with Bavarian Nordic’s board chair departing
read moreAscendis Pharma is spiraling upward by way of its TransCon platform. For the third time in six years, the Copenhagen-based biopharma has scored an FDA approval for a rare disease medicine that was developed with its “transient conjugation” drug delivery
read more© 1994 - 2026 B.M. Pharmaceuticals